(2S,3S,5R)-3-((Z)-2-Cyano-vinyl)-3-methyl-4,4,7-trioxo-4lambda*6*-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid

ID: ALA333078

Chembl Id: CHEMBL333078

PubChem CID: 9860224

Max Phase: Preclinical

Molecular Formula: C10H10N2O5S

Molecular Weight: 270.27

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Ro-481220 | CHEMBL333078|Ro-481220|SCHEMBL1686888|BDBM50053184|(2S,3S,5R)-3-((Z)-2-Cyano-vinyl)-3-methyl-4,4,7-trioxo-4lambda*6*-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid|(2S,3S,5R)-3-(2-Cyano-vinyl)-3-methyl-4,4,7-trioxo-4lambda 6-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid

Canonical SMILES:  C[C@]1(/C=C\C#N)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O

Standard InChI:  InChI=1S/C10H10N2O5S/c1-10(3-2-4-11)8(9(14)15)12-6(13)5-7(12)18(10,16)17/h2-3,7-8H,5H2,1H3,(H,14,15)/b3-2-/t7-,8+,10+/m1/s1

Standard InChI Key:  JYGFUXUBGZBBAC-BJTZKDDDSA-N

Associated Targets(non-human)

Bacillus licheniformis (140 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ampC Beta-lactamase (730 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterobacter cloacae (7976 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Citrobacter freundii (1864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
blaACC-4 Beta-lactamase ACC-4 (27 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
sugE Efflux transporter (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
bla Class C beta-lactamase CMY-36 (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 270.27Molecular Weight (Monoisotopic): 270.0310AlogP: -0.74#Rotatable Bonds: 2
Polar Surface Area: 115.54Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 1.66CX Basic pKa: CX LogP: -0.87CX LogD: -4.39
Aromatic Rings: Heavy Atoms: 18QED Weighted: 0.52Np Likeness Score: 0.67

References

1. Richter HG, Angehrn P, Hubschwerlen C, Kania M, Page MG, Specklin JL, Winkler FK..  (1996)  Design, synthesis, and evaluation of 2 beta-alkenyl penam sulfone acids as inhibitors of beta-lactamases.,  39  (19): [PMID:8809160] [10.1021/jm9601967]
2. Papagiannitsis CC, Tzouvelekis LS, Tzelepi E, Miriagou V..  (2007)  Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.,  51  (10): [PMID:17664321] [10.1128/aac.00389-07]
3. Zioga A, Whichard JM, Kotsakis SD, Tzouvelekis LS, Tzelepi E, Miriagou V..  (2009)  CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.,  53  (3): [PMID:19104021] [10.1128/aac.01284-08]
4. Kotsakis SD, Papagiannitsis CC, Tzelepi E, Tzouvelekis LS, Miriagou V..  (2009)  Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.,  53  (8): [PMID:19470510] [10.1128/aac.00219-09]

Source